Abstract:Recently, a growing number of biological research and scientific experiments have demonstrated that microRNA (miRNA) affects the development of human complex diseases. Discovering miRNA-disease associations plays an increasingly vital role in devising diagnostic and therapeutic tools for diseases. However, since uncovering associations via experimental methods is expensive and time-consuming, novel and effective computational methods for association prediction are in demand. In this study, we developed a computational model of Matrix Decomposition and Heterogeneous Graph Inference for miRNA-disease association prediction (MDHGI) to discover new miRNA-disease associations by integrating the predicted association probability obtained from matrix decomposition through sparse learning method, the miRNA functional similarity, the disease semantic similarity, and the Gaussian interaction profile kernel similarity for diseases and miRNAs into a heterogeneous network. Compared with previous computational models based on heterogeneous networks, our model took full advantage of matrix decomposition before the construction of heterogeneous network, thereby improving the prediction accuracy. MDHGI obtained AUCs of 0.8945 and 0.8240 in the global and the local leave-one-out cross validation, respectively. Moreover, the AUC of 0.8794+/-0.0021 in 5-fold cross validation confirmed its stability of predictive performance. In addition, to further evaluate the model's accuracy, we applied MDHGI to four important human cancers in three different kinds of case studies. In the first type, 98% (Esophageal Neoplasms) and 98% (Lymphoma) of top 50 predicted miRNAs have been confirmed by at least one of the two databases (dbDEMC and miR2Disease) or at least one experimental literature in PubMed. In the second type of case study, what made a difference was that we removed all known associations between the miRNAs and Lung Neoplasms before implementing MDHGI on Lung Neoplasms. As a result, 100% (Lung Neoplasms) of top 50 related miRNAs have been indexed by at least one of the three databases (dbDEMC, miR2Disease and HMDD V2.0) or at least one experimental literature in PubMed. Furthermore, we also tested our prediction method on the HMDD V1.0 database to prove the applicability of MDHGI to different datasets. The results showed that 50 out of top 50 miRNAs related with the breast neoplasms were validated by at least one of the three databases (HMDD V2.0, dbDEMC, and miR2Disease) or at least one experimental literature.

Inferring Disease-Related Domain Using Network-Based Method

Potential Pathogenic Genes Prioritization Based on Protein Domain Interaction Network Analysis.

Defining disease-related modules based on weighted miRNA synergistic network

Comparative Study of Network-Based Prioritization of Protein Domains Associated with Human Complex Diseases

DomainRBF: a Bayesian Regression Approach to the Prioritization of Candidate Domains for Complex Diseases

Network-based Distance Metric with Application to Discover Disease Subtypes in Cancer

Decoding Immune Heterogeneity of Melanoma and identifying immune-prognostic hub genes

A knowledge-driven network for fine-grained relationship detection between miRNA and disease

MDHGI: Matrix Decomposition and Heterogeneous Graph Inference for Mirna-Disease Association Prediction

Development of an immune-related gene pairs index for the prognosis analysis of metastatic melanoma

Bioinformatic Analysis of Differentially Expressed Genes in Metastatic Melanoma

Integrative Analysis for Identifying Co-Modules of Microbe-Disease Data by Matrix Tri-Factorization With Phylogenetic Information

Systematic Tracking of Coordinated Differential Network Motifs Identifies Novel Disease-Related Genes by Integrating Multiple Data

A network-based machine-learning framework to identify both functional modules and disease genes

Identification of Epigenetically Altered Genes and Potential Gene Targets in Melanoma Using Bioinformatic Methods

Network-Based Approaches to Explore Complex Biological Systems towards Network Medicine

DF-MDA: An effective diffusion-based computational model for predicting miRNA-disease association

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma

Identification of IL10RA by Weighted Correlation Network Analysis and in vitro Validation of Its Association With Prognosis of Metastatic Melanoma

Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis

Identifying novel circadian rhythm biomarkers for diagnosis and prognosis of melanoma by an integrated bioinformatics and machine learning approach